What URMC Labs Actually Do Now
University of Rochester Medical Center has been shifting its lab operations for the last several years. They consolidated a lot of research infrastructure into a few key buildings on the medical center campus and in the surrounding innovation district. The main sites you will run into are the Golisano Children's Hospital research wing, the cluster near Highland Avenue, and the newer facilities tied to the Center for Imaging Sciences. Each one focuses on different things — pediatric studies, imaging research, molecular diagnostics, and clinical translation work. The way to actually use these labs depends on what you are trying to do. If you are a clinician looking to run a trial, you go through the URMC Clinical and Translational Science Institute (CTSI). They handle protocol review, IRB coordination, and site setup. Turnaround is usually 4 to 6 weeks for standard approvals. If you are a researcher from outside URMC who wants collaborative access, you need a formal affiliation or sponsorship from a principal investigator already at the institution. That step alone can take 2 to 3 weeks depending on how busy the relevant department is. I ran into a problem once when a collaborator tried to book imaging time on a shared MRI platform at URMC without realizing the scheduling system was split across two different departments. They had an appointment through the radiology side, but the actual scan sequence needed approval from the research imaging core. Lost about four days waiting on that clarification. The workaround was straightforward — get your PI to email the research imaging coordinator directly and ask them to cross-reference your booking. It takes five minutes if you know who to contact. Most people just call the general line and bounce around until someone tells them the right email address.
Access levels matter more than people expect. Not every lab location is open to every type of work. Biosafety level 2 and above work requires separate clearance through Environmental Health and Safety. Regular clinical labs operate under CLIA certification, which means outside researchers can't just walk in and start processing samples. You need a designated lab space assigned to you, and that space has to be approved for the specific procedures you plan to run. I have seen people assume they could take samples back to their home institution after running initial tests at URMC. That only works if the receiving lab is also CLIA-certified and there is a written transfer agreement in place. Without one, those results are not valid for clinical decision-making. Another thing that catches people off guard is the cost structure. URMC labs are not free just because you have a research grant. Equipment usage, especially for advanced imaging and flow cytometry, runs on an internal billing model. Rates vary by instrument and by whether you are faculty, postdoc, or industry partner. Industry rates are typically 40 to 60 percent higher than academic rates. Budget for that if you are working through a commercial sponsor. Faculty and trainees usually get subsidized rates through their department's overhead arrangement. If you are planning to move samples between locations, do it through the institutional courier system. External couriers are not always accepted inside the secure research buildings, and some facilities require temperature-controlled transfer documentation that external services do not always provide. The internal system logs chain of custody automatically, which matters if you are ever audited or if a sample gets rejected downstream.
The new innovation district facilities are where most of the translational work happens now. They are designed to bridge bench research and clinical application, which means they house equipment that is more expensive and more specialized than what you would find in a standard departmental lab. Core facilities like the Genomics and Protein Expression labs are open to the broader research community but require training certification before you can use them independently. That training usually takes one full day and includes a competency assessment. You cannot skip it, even if you have extensive experience elsewhere. Scheduling through the centralized portal is mostly reliable, but peak demand periods create bottlenecks. Mid-year and end-of-fiscal-year are the worst times. If your project timeline is tight, book at least six to eight weeks out. Last-minute requests get deprioritized, and you will spend more time waiting than actually working. Paperwork is another area where people slow themselves down. IRB protocols, biosafety forms, and material transfer agreements all live in different tracking systems. URMC has been working to unify some of this, but it is not complete. Keep a master spreadsheet with submission dates, tracking numbers, and expected approval windows. I found that missing a single renewal date on a biosafety permit once caused a lab access suspension that set a project back three weeks. The permit had expired by two days, and the system auto-revoked access.
Get the Full Details

If you are affiliated with an external institution and want to use URMC facilities, establish a Memorandum of Understanding early. Some collaborators wait until they are ready to submit data before sorting this out. By then, you are already behind. An MOU takes about two weeks to finalize if both institutions are responsive. It covers liability, data ownership, and resource sharing terms, and it prevents conflicts later when publication or licensing decisions come up.
What Works in Practice
The most efficient path through URMC's research infrastructure is straightforward if you respect the process. Identify your target lab or core facility. Confirm access requirements with the facility manager. Get your PI or sponsor letter in hand. Complete any mandatory training modules before you schedule equipment time. Submit IRB or biosafety documentation in parallel rather than sequentially. Build buffer time into your project plan for the administrative steps. It is not perfect. Bureaucracy is real, and some of the legacy systems still feel like they were built in the early 2000s. But the infrastructure itself is solid, and the researchers who understand how to navigate it get reasonable access to some of the better-equipped medical research facilities in the region.